baber/WOPTO huggingface dataset:
Patent NZ-586513-A (NZ)
Title: A method and a transmitting unit for reducing a risk of transmission stalling between a transmitting unit and a receiving unit in a communication network system
Inventor: PERSSON HAKAN
IPC: H04L1/16
Filed: 2008-12-22
Abstract: A method and a transmitting unit for reducing a risk of transmission stalling between a transmitting unit (32, 33, 36) and a receiving unit (31, 34, 37) in a communication network system are disclosed. The transmitting unit is arranged to transmit data blocks to the receiving unit. Each data block comprises a block sequence number and transmitted data blocks are stored in a transmission buffer and a transmission buffer window is arranged to control the flow of retransmission of the transmitted data blocks. The transmission buffer window comprises an acknowledge state variable, V(A) and V(A) contains the block sequence number value of the oldest data block that has not been positively acknowledges by its peer. When the block sequence number has been acknowledged in a piggybacked acknowledgement/negative acknowledgement field, the transmitting unit is arranged to set the block sequence number as tentative acknowledged, and then to set the block sequence number as acknowledged upon receipt of a packet uplink acknowledgement/negative acknowledgement message or a packet downlink acknowledgement/negative acknowledgement message comprising an acknowledgement for the block sequence number. When the block sequence number is set as acknowledged, the transmitting unit is, only then, further arranged to advance the transmission buffer window to the acknowledge state variable, V(A), [BSN' + 1] modulo SNS. BSN' is the block sequence number and SNS is a sequence number space. An user equipment (18) comprising the above described transmitting unit and a communication network node (10, 15) comprising the above described transmitting unit are also disclosed.
Patent NZ-586972-A (NZ)
Title: Method for determination of sensitivity to anti-cancer agent
Inventor: TANIGAWARA YUSUKE
IPC: G01N33/574
Filed: 2009-01-30
Abstract: The use of the calcium-binding protein S100A7, S100A8 or S100A10 as a maker for determining the sensitivity of a subject who has colorectal cancer to the anti-cancer agents oxaliplatin, cisplatin, irinotecan or SN-38.
Patent NZ-587546-A (NZ)
Title: Upright tubular foldable display with foldable inner retaining member and detachable base stand
Inventor: KAWAGUCHI TOMOYA
IPC: B65D5/486
Filed: 2010-08-24
Abstract: An upright display stand having a vertical main body of two curved faces, which can be folded to lie flat or unfolded into a tubular shape. A plurality of foldable retainers keeps the body in the unfolded state. The retainer can be laid flat to allow the body to lie flat. The body edges are joined together via a continuous series of tabs and plates that interlock with each other. The body joins a one piece horizontal folded foot stand via cut slots to support the body.
Patent NZ-595345-A (NZ)
Title: Active ingredient combinations with insecticidal and acaricidal properties
Inventor: FISCHER REINER
IPC: A01N47/06
Filed: 2009-03-25
Abstract: 595345 Disclosed herein are active compound combinations comprising at least one compound of formula (I), wherein the variables are defined in the specification, and at least one tetronic or tetramic acid compound, such as spirotetramat, spirodiclofen, spiromesifen; and the use thereof as an insecticide or acaracide for treating seed. Embodiments of the compound of formula (I) include the following: 4-{ [(6-bromopyrid-3-yl)methyl](2-fluoroethyl)amino} furan-2(5H)-one, and 4-{ [(2-chloro-l,3-thiazol-5-yl)methyl](2-fluoroethyl)amino} furan-2(5H)-one.
Patent NZ-595448-A (NZ)
Title: Hydroxythienoquinolones and related compounds as anti-infective agents
Inventor: BRADBURY BARTON JAMES
IPC: C07D495/04
Filed: 2010-04-05
Abstract: Disclosed herein are hydroxythienoquinolones and related compounds and their pharmaceutically acceptable salts useful as antiviral agents and having the general formula (I) in which the variables R2, R6, and R7 are defined herein. Certain compounds provided herein possess potent antibacterial, antiprotozoal, or antifungal activity and are particularly efficacious for the treatment of MRSA infections. The disclosure also provides pharmaceutical compositions, pharmaceutical compositions containing a hydroxythienoquinolone in combination with one or more other active agent, and methods of treating microbial infections in animals by administering an effective amount of a hydroxythienoquinolone or related compound to an animal suffering from a microbial infection.
Patent NZ-595850-A (NZ)
Title: DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND Beta2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
Inventor: HUGHES ADAM
IPC: A61K31/444
Filed: 2010-04-16
Abstract: 595850 Disclosed is a compound of formula I, or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein. Such compounds possess both muscarinic receptor antagonist and [beta]2 adrenergic receptor agonist activities. The invention also relates to pharmaceutical compositions comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compounds as bronchodilating agents to treat pulmonary disorders. Specific embodiments of the compound include: biphenyl-2-ylcarbamic acid 1-[2-({ 3-[2-(3-{ (S)-2-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]propyl} phenyl)acetylamino]propyl} methylcarbamoyl)-ethyl]piperidin-4-yl ester, and 1-{ 2-[(4-{ [2-(3-{ (R)-2-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]propyl} phenyl)ethylcarbamoyl]methyl} phenyl)-methylcarbamoyl]ethyl} piperidin-4-yl ester.
Patent NZ-597079-A (NZ)
Title: Restoring power to loads in a controlled way based on load importance groups
Inventor: BLACK JASON WAYNE
IPC: H02H3/00
Filed: 2011-12-13
Abstract: Disclosed is a method for managing cold load pickup using demand response. The method is performed by estimating pickup load on a feeder (412) in a distribution network and determining a load limit on the feeder (414). The actual load on the feeder is divided into groups based on the load limit of the feeder (416). The groups are based on a determination of critical loads requiring immediate turn-on and non-critical loads having a delayed turn-on. A power restoration control process for restoring power to each of the groups is then identified. Power is then restored to each of the groups simultaneously (418) based on the power restoration control process.
Patent NZ-598438-A (NZ)
Title: Adhesive bandage with absorbent pad having interconnected channel regions of higher density than rest of pad and being visible from a distance
Inventor: CHAN JENNIFER WING-YEE
IPC: A61F13/533
Filed: 2012-02-27
Abstract: An adhesive bandage has a backing layer with an absorbent pad attached to it with adhesive. The pad has raised tufted regions separated by lower channel regions of a greater density than the raised regions. Each of the tufted regions is not a polygon of four to eight sides.
Patent NZ-598888-A (NZ)
Title: Method for manufacturing low-phosphorus whey
Inventor: SEKI NOBUO
IPC: A23L33/00
Filed: 2010-09-24
Abstract: Disclosed herein is a method of manufacturing a low-phosphorus whey, the method comprising: subjecting a raw whey liquid to a demineralization treatment using a nanofiltration method to obtain a low-chloride whey liquid in which a chloride content has been reduced to not more than 30 mmol per 100 g of solids, and passing the low-chloride whey liquid through an ion exchange resin, wherein the ion exchange resin comprises an anion exchange resin, and at least an anion exchange resin in chloride form is used as the anion exchange resin, wherein the pH of the raw whey liquid is within a range from 6 to 7, and a pH of the low-chloride whey liquid and a pH of an eluate from the anion exchange resin are both within a range from 6 to 7 and a combined total of a calcium content and a magnesium content is at least 10 mmol per 100 g of solids.
Patent NZ-599949-A (NZ)
Title: Drug combination with theobromine and its use in therapy
Inventor: BREW JOHN
IPC: A61K31/485
Filed: 2010-11-12
Abstract: Abstract 599949 The disclosure relates to an agent consisting of theobromine and another non-opiate antitussive, for use in therapy. Preferably, the therapy is of cough. The non-opiate antitussive (preferably a N-methyl-D-aspartate [NMDA] receptor antagonist) may be any of dextromethorphan, isoaminile, benzonate, zipeprol, morclofone, prenoxdiazine, dropropizine, piperidione, pentoxyverine, oxolamine, oxeladin, nepinalone, meprotixol, indantadol, dimemorfan, dibunate, cloperastine, clofedanol, butamirate, bibenzonium, benproperine and fedrilate.
Patent NZ-601400-A (NZ)
Title: Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use
Inventor: DZIEWISZEK WOJCIECH
IPC: A61K35/36
Filed: 2011-01-26
Abstract: Disclosed is a bioactive cell homogenate produced from cells belonging to the MIC-1 stem cell line derived from growing deer antlers (Cervidae) deposited at the DSMZ under the accession DSM ACC2854, a method of producing and using it. The present invention also encompasses a pharmaceutical or cosmetic composition containing the above-mentioned homogenate.
Patent NZ-607966-A (NZ)
Title: Quinoline and quinoxaline derivatives as kinase inhibitors
Inventor: PARTON ANDREW HARRY
IPC: C07D471/04
Filed: 2011-09-02
Abstract: The disclosure relates to a series of quinoline and quinoxaline derivatives comprising a fluorinated ethyl side-chain, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. Compounds of the disclosure include:, N-{(R)-1-[8-chloro-2-(1-oxypyridin-3-yl)quinolin-3-yl]-2,2,2-trifluoroethyl}pyrido[3,2-d]pyrimidin-4-ylamine,, N-{(R)-1-[8-(Methanesulfonyl)-2-(2-methyl-1-oxypyridin-3-yl)quinolin-3-yl]-2,2,2-trifluoroethyl}pyrido[3,2-d]pyrimidin-4-amine, and, N-{(R)-1-[8-Chloro-2-(6-chloropyridin-3-yl)quinolin-3-yl]-2,2,2-trifluoroethyl}pyrido[3,2-d]pyrimidin-4-ylamine.
Patent NZ-609338-A (NZ)
Title: Laundry detergents based on compositions derived from natural oil metathesis
Inventor: ALONSO MARCOS
IPC: C11D3/20
Filed: 2011-10-25
Abstract: The disclosure relates to a laundry detergent comprising an anionic surfactant selected from the group consisting of C4-C30 carboxylates, fatty alkyl sulfates, fatty alkyl ether sulfates, paraffin sulfonates, olefin sulfonates, alkyl aryl sulfonates, fatty ester sulfonates, sulfosuccinate esters, and organic phosphates; a nonionic surfactant selected from the group consisting of fatty alcohols, fatty alcohol alkoxylates, alkylphenol alkoxylates, ether-capped fatty alcohol alkoxylates, alkoxylated fatty esters, alkoxylate block copolymers, alkylpolysaccharides, alkoxylated fatty amides, polyhydroxy fatty amides, fatty amine oxides, castor oil alkoxylates, polyol esters, glycerol esters, glycol fatty esters, and tallow amine ethoxylates; a fatty alkyl ester sulfonate; and a surfactant composition derived from a metathesis-derived C10-C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives and selected from the group consisting of C10 betaines, C12 or C16 amidoamines, C12 ethanolamine amides, C16 amidoamine sulfonates, C18 diamidoamine dioxides, quaternized d e diamidoamine betaines, sulfonated C18 low-EO fatty ester alkoxylates, C18 amidoamine carboxylates, and amidoamine oxides and sulfobetaines derived from cross-metathesis of palm or soybean oil. The disclosure also related to a boosted bargain laundry detergent comprising an comprising an anionic surfactant, a nonionic surfactant, and a performance booster derived from a metathesis-derived C10- C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives and selected from the group consisting of C12 low-EO fatty ester alkoxylate sulfonates, C18 amidoamine oxide esters, C18 amidoamine oxide carboxylates, and amidoamine sulfobetaines made from self-metathesized palm or soybean oil.
Patent NZ-618218-A (NZ)
Title: Method and apparatus for energy-efficient processing of secondary deposits
Inventor: HOFER WOLFGANG
IPC: C10G1/10
Filed: 2012-05-04
Abstract: Specification discloses a method and apparatus for the depolymerisation of plastics material (1), in particular in recycling plastic waste, by means of heat introduction. Plastics material is molten to form a plastics melt and degassed before being passed to a depolymerisation reactor (3) having a heating device (3’). A heavy oil, having a final boiling point of > 300 °C and having a share of aromatic hydrocarbons of at least 25% added to a supply circuit (4) via a solvent introduction device (6’) to improve viscosity of the plastics melt.
Patent NZ-624317-A (NZ)
Title: Overload and elute chromatography
Inventor: NADARAJAH DEEPA
IPC: B01D15/08
Filed: 2012-11-02
Abstract: Disclosed is a method for purifying an antibody from a composition comprising the antibody and one or more contaminants, said method comprising a) loading the composition onto a chromatography material in an amount in excess of the dynamic binding capacity of the chromatography material for the antibody, b) eluting the antibody from the chromatography material under conditions wherein the one or more contaminants remain bound to the chromatography material, and c) pooling fractions comprising the antibody in the chromatography effluent from steps a) and b), wherein the loading density of the composition is between about 200 g/L to about 1000 g/L and wherein the method further comprises the use of a loading buffer and an elution buffer, wherein the elution buffer has a conductivity less than the conductivity of the loading buffer.
Patent NZ-629189-A (NZ)
Title: Liver x receptor modulators
Inventor: DONG CHENGGUO
IPC: C07D487/04
Filed: 2013-03-14
Abstract: Disclosed herein are Pyrimidine substituted dihydrobenzo[4,5]imidazo[1,2-a]pyrazine compounds of the general formula shown and pharmaceutically acceptable salts thereof that are liver X receptor modulators. Also provided are compositions comprising compounds of the invention and a carrier and use of the compounds for treating a disease or disorder associated with the liver X receptor. Specific examples of the compounds are: (R)-2-(8-(hydroxymethyl)-1-isopropyl-7-(methylsulfonyl)-3,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrazin-2(1H)-yl)-N-methyl-4-(trifluoromethyl)pyrimidine-5-carboxamide and (R)-2-(2-(8-(hydroxymethyl)-1-isopropyl-7-(methylsulfonyl)-3,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrazin-2(1H)-yl)-4-(trifluoromethyl)pyrimidin-5-yl)propan-2-ol.
Patent NZ-708840-A (NZ)
Title: Carton and carton blank
Inventor: PSALIDAS MARIA
IPC: B65D71/22
Filed: 2012-02-10
Abstract: A carton for packaging one or more articles (B), includes a series of main panels hinged one to the next to form a tubular structure. The tubular structure includes a top panel, first and second side panels and a base panel and at least one display window struck from at least one of the side panels. The at least one window extends from the top panel to the base panel and is interrupted by a retention strap. Part of window is formed from curved weakened line forming a warped surfaced of side panel.
Patent NZ-717490-A (NZ)
Title: Methods of treating cancer
Inventor: SOON-SHIONG PATRICK
IPC: A61P35/00
Filed: 2011-03-28
Abstract: Provided is the use of a composition comprising nanoparticles comprising paclitaxel and an albumin in the manufacture of a medicament for treating non-small cell lung cancer (NSCLC), wherein the medicament is to be administered with a platinum-based agent, wherein treatment is based on the patient being at least 70 years old and the NSCLC being squamous cellular carcinoma. Further provided are methods of assessing whether a patient will respond to a treatment comprising nanoparticles comprising paclitaxel and an albumin and a platinum-based agent on basis that the cancer is squamous cell carcinoma and the patient is at least 70 years old.
Patent NZ-717633-A (NZ)
Title: Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
Inventor: PIMENTEL MARK
IPC: G01N33/00
Filed: 2014-10-09
Abstract: The present invention describes methods diagnosing irritable bowel syndrome (IBS) and distinguising IBS from inflammatory bowel disease (IBD) when anti-vinculin anitibody level is determined higher than anti-CdtB antibody level in a biological sample from a subject.
Patent NZ-732353-A (NZ)
Title: A guard for a post
Inventor: ANTHONY PETER OVERBEEK
IPC: E04H17/20
Filed: 2016-05-31
Abstract: The invention is a guard for a fence or gate post. In use, the guard is located about or proximate the base of the post and secured using anchoring means such as pegs that are inserted through at least two channels running between the top and bottom surfaces of the body of the guard such that they penetrate the ground. When positioned in this manner, the front face of the invention, which is outwardly curved, provides a smooth contact surface against which a hose or irrigation pod may bear should it contact the invention as it is being towed or dragged past. There is a reduced risk of the hose or pod being damaged or sudden application of tension which may otherwise cause the user of a vehicle towing the hose to fall or be injured against a part of the towing vehicle.
Patent NZ-738034-A (NZ)
Title: A foam-based interfacing structure method and apparatus
Inventor: VELISS LEE JAMES
IPC: A62B9/06
Filed: 2009-09-03
Abstract: A facial mask assembly for use in providing a supply of air at pressure to the entrance of the airways of a person, the mask assembly including a frame and a cushion (932) supported by the frame. The cushion is formed at least in part from foam, and has a circumference and a cross-section. At least a portion of the cross section of the cushion includes a base side defined by a base surface of the cushion, an outer side defined by an outer surface of the cushion and an inner side defined by an inner surface of the cushion, the outer side and inner side extending away from the base side and intercepting each other at an apex to define a generally triangular cross-section. The base surface is arranged to face the frame, the inner surface is orientated to face a centre of the mask, and the outer surface is orientated to face away from the centre of the mask. The mask assembly is arranged to promote a rolling-in effect at least in a selected region of the circumference of the cushion on application of force to the cushion in-use, the rolling-in effect causing a portion of the outer surface of the cushion to form a seal with the face of the patient.
Patent NZ-761384-A (NZ)
Title: Novel crop fortification, nutrition and crop protection composition
Inventor: SAWANT ARUN VITTHAL
IPC: C05G3/70
Filed: 2018-07-14
Abstract: The invention relates to an algal composition in the form of an aqueous suspension. More particularly the invention relates to aqueous suspension compositon including one or more algae selected from green algae, red algae, golden algae, brown algae, golden- brown algae, blue algae, blue-green algae or their species in the range of 0.1%-65% by weight with one or more surfactants in the range of 0.1% -50% by weight; with one or more structuring agent in the range of 0.01%-5% by weight, where the composition has a particle size range of from 0.1 micron to 60 microns. Furthermore, the invention relates to a process of preparing the algal composition comprising at least one alga and at least one agrochemically acceptable excipient in the form of an aqueous suspension. The invention further relates to a method of treating the plants, seeds, crops, plant propagation material, locus, parts thereof or the soil with the algal composition in the form of aqueous suspension.
Patent PT-102406-A (PT)
Title: Hydraulic control valve for a vehicle power steering system has concentric sleeves around steering column with fluid flow channels on outer surfaces connected as sleeves move relative to each other also pressure relief valve
Inventor: BAPTISTA FERNANDO AUGUSTO
IPC: B62D5/06
Filed: 2000-01-21
Abstract: The valve has concentric sleeves (A & B) around the steering shaft (D0) with the inner held by springs (F) to the shaft and slots for bolts (E) in the outer ring restrict relative movement. Relative movement of sleeves aligns hydraulic fluid flow channels cut in the rings. Valve also includes progression valve operated by engine vacuum and safety valve (P1) to close on low hydraulic level leaving easy manual only control of steering.
Patent PT-103870-A (PT)
Title: Sistema integrado de monitorização e controlo de postos de trabalho
Inventor: AMARAL JORGE PAULO DA SILVA
IPC: G05B19/418
Filed: 2007-10-29
Abstract: O PRESENTE INVENTO DIZ RESPEITO A UM SISTEMA PARA MONITORIZAÇÃO E CONTROLO DE POSTOS DE TRABALHO QUE INDICA AO OPERADOR A REFERÊNCIA/OPERAÇÃO EM EXECUÇÃO, A PERCENTAGEM DE EFICIÊNCIA DA REFERÊNCIA/OPERAÇÃO, A SEQUÊNCIA DE REFERÊNCIAS/SEQUÊNCIAS A EXECUTAR, A RELAÇÃO ENTRE O TEMPO ESTIMADO E O TEMPO DECORRIDO. PARA ESSE EFEITO, ESTE SISTEMA COMPREENDE MÓDULOS INDIVIDUAIS (1) QUE PODEM SER LIGADOS EM REDE ATRAVÉS DE UM MÓDULO DE COMUNICAÇÃO (2), SUPORTADO EM REDES DE DADOS ETHERNET, PERMITINDO CENTRALIZAR A INFORMAÇÃO NUMA APLICAÇÃO DE MONITORIZAÇÃO E CONTROLO (3), EM TEMPO REAL, DE TODOS OS MÓDULOS. ASSIM, O PRESENTE INVENTO TERÁ APLICAÇÃO EM TODO O TIPO DE EMPRESAS E INSTITUIÇÕES QUE UTILIZEM POSTOS DE TRABALHO POIS PERMITE MONITORIZAÇÃO E CONTROLO, EM TEMPO REAL, TODOS OS MÓDULOS E, CONSEQUENTEMENTE, TODAS A TAREFAS A SEREM REALIZADAS.
Patent PT-104030-A (PT)
Title: Máquina de fornecimento urbano de energia eólica/ solar
Inventor: MARINHA PEDRO SANTA
IPC: H02S10/12
Filed: 2008-03-03
Abstract: MÁQUINA DE FORNECIMENTO URBANO DE ENERGIA EÓLICA E SOLAR. ESTE INVENTO É CARACTERIZADO POR SER UMA MÁQUINA/APARELHO PARA FORNECER ELECTRICIDADE URBANA, DESDE APARTAMENTOS A LOCAIS ISOLADOS, SÃO INSTALADOS JUNTO DAS CHAMINÉS COM O INTUITO DA ESTÉTICA NÃO SER ALTERADA. INCLUI UMA ESTRUTURA FABRICADA À MEDIDA.
Patent PT-104115-A (PT)
Title: Sistema de monitorização de temperatura central para diagnósticos de distúrbios de sono
Inventor: SANCHES JOAO MIGUEL RAPOSO
IPC: H04M1/725
Filed: 2008-06-26
Abstract: NO PRESENTE EVENTO É APRESENTADO UM SISTEMA DE DIAGNÓSTICO DE DISTÚRBIOS DE SONO A PARTIR DE UM EQUIPAMENTO SIMPLES PARA PROCEDER À MEDIÇÃO CONTINUA DA TEMPERATURA DO CORPO HUMANO NO PAVILHÃO AURICULAR. UM SENSOR DE TEMPERATURA ELECTRÓNICO, ACOPLADO AO MICROFONE DE UM AURICULAR BLUETOOTH (1), ENVIA AS MEDIÇÕES DA TEMPERATURA PARA O TELEMÓVEL AO QUAL SE ENCONTRA EMPARELHADO. COM A INFORMAÇÃO ADQUIRIDA É DETERMINADO O CICLO CIRCADÍANO DA TEMPERATURA A PARTIR DO QUAL SE PODEM DIAGNOSTICAR DETERMINADOS DISTÚRBIOS DO CICLO CIRCADIANO DO SONO/VIGÍLIA HUMANO. AS MEDIDAS SÃO GUARDADAS NA MEMÓRIA DO TELEMÓVEL E PERIODICAMENTE ENVIADAS VIA E-MAIL OU SMS (SHORT MESSAGING SERVICE) PARA UM CENTRO CLÍNICO. DADO QUE NÃO SÃO UTILIZADOS FIOS, O SISTEMA PERMITE UMA UTILIZAÇÃO DE LONGA DURAÇÃO E DE FORMA CONTÍNUA SEM DESCONFORTO PARA O PACIENTE. A ELECTRÓNICA ESTÁ MUITO SIMPLIFICADA E MINIATURIZADA VISTO SER COMPOSTA POR UM SIMPLES SENSOR DE TEMPERATURA (2), QUE MODULA EM FREQUÊNCIA UMA PORTADORA SINUSOIDAL DE ÁUDIO. ESTA É INJECTADA NO MICROFONE DO AURICULAR E ENVIADA PARA O TELEMÓVEL ATRAVÉS DO CANAL DE VOZ.
Patent RU-94007597-A (RU)
Inventor: MARINJUK B T
IPC: F25C1/12
Filed: 1994-02-25
Abstract: FIELD: refrigerating engineering. SUBSTANCE: evaporating elements are placed in hermetic envelopes made from synthetic films, then they are evacuated and layer of ice of required thickness is frozen on it, after which evacuation is discontinued and atmospheric air is admitted inside hermetic envelopes. EFFECT: increase of productivity by 3 to 4.5 times. 2 cl, 1 dwg